APA

Wiegering A., Korb D., Thalheimer A., Kämmerer U., Allmanritter J., Matthes N., Linnebacher M., Schlegel N., Klein I., Ergün S., Germer C. & Otto C. (20150720). E7080 (lenvatinib), a multi-targeted tyrosine kinase inhibitor, demonstrates antitumor activities against colorectal cancer xenografts. : Neoplasia (New York, N.Y.).

Chicago

Wiegering Armin, Korb Doreen, Thalheimer Andreas, Kämmerer Ulrike, Allmanritter Jan, Matthes Niels, Linnebacher Michael, Schlegel Nicolas, Klein Ingo, Ergün Süleyman, Germer Christoph-Thomas and Otto Christoph. 20150720. E7080 (lenvatinib), a multi-targeted tyrosine kinase inhibitor, demonstrates antitumor activities against colorectal cancer xenografts. : Neoplasia (New York, N.Y.).

Harvard

Wiegering A., Korb D., Thalheimer A., Kämmerer U., Allmanritter J., Matthes N., Linnebacher M., Schlegel N., Klein I., Ergün S., Germer C. and Otto C. (20150720). E7080 (lenvatinib), a multi-targeted tyrosine kinase inhibitor, demonstrates antitumor activities against colorectal cancer xenografts. : Neoplasia (New York, N.Y.).

MLA

Wiegering Armin, Korb Doreen, Thalheimer Andreas, Kämmerer Ulrike, Allmanritter Jan, Matthes Niels, Linnebacher Michael, Schlegel Nicolas, Klein Ingo, Ergün Süleyman, Germer Christoph-Thomas and Otto Christoph. E7080 (lenvatinib), a multi-targeted tyrosine kinase inhibitor, demonstrates antitumor activities against colorectal cancer xenografts. : Neoplasia (New York, N.Y.). 20150720.